Endocrinology, Vol 132, 489-495, Copyright © 1993 by Endocrine Society

ARTICLES

Estrogen-induced calbindin-D 9k gene expression in the rat uterus during the estrous cycle: late antagonistic effect of progesterone

F L'Horset, C Blin, A Brehier, M Thomasset and C Perret
INSERM U 120, Hopital Robert Debre, Paris, France.

Progesterone modulates estrogen-stimulated responses in the uterus. Calbindin-D 9k (CaBP9k), a 17 beta-estradiol-responsive gene expressed in the uterus, was used as a marker to examine the interactions between endogenous progesterone and estradiol in the rat. The variations in uterine CaBP9k messenger RNAs (mRNAs) during the rat estrous cycle indicated that CaBP9k gene expression was greatest during the estrogen- dominated phases (proestrus and estrus) and became totally repressed during diestrus, when progesterone predominates. Estradiol was found to be the major controlling factor of CaBP9k gene expression in vivo, progesterone antagonizing estrogen-induced CaBP9k gene expression. The inhibitory role of progesterone was further examined in two experiments. Mature cyclic rats were injected with the progesterone antagonist RU486 before the progesterone surge of proestrus, and the estrous cycle was mimicked in ovariectomized rats by sequential injections of estrogen and progestin. Progesterone did not appear to be involved in the rapid decrease in CaBP9k mRNA during estrus but was implicated in the down-regulation of the estrogen-stimulated CaBP9k gene expression at the end of estrus and during diestrus. This delayed effect of progesterone was confirmed in the ovariectomized rat model. CaBP9k mRNA accumulation in estrogen-primed ovariectomized rats was suppressed by estrogen followed 1 h later by the progesterone agonist R5020. This effect occurred more than 24 h after progestin treatment. The inhibition of the estrogen-induced CaBP9k gene expression in the rat uterus by progesterone is certainly mediated by the progesterone receptor, because progesterone had no effect without estrogen priming or when the antagonist RU486 was used. The delayed progesterone effect probably does not involve depletion of nuclear estrogen receptors, the major rapid mechanism proposed for estrogen inhibition by progesterone in the rodent uterus, or control of estrogen receptor synthesis, as shown by Northern blot analysis of estrogen receptor mRNA.

This article has been cited by other articles:

				T. T. B. Vo and E.-B. Jeung An Evaluation of Estrogenic Activity of Parabens Using Uterine Calbindin-D9k Gene in an Immature Rat Model Toxicol. Sci., November 1, 2009; 112(1): 68 - 77. [Abstract] [Full Text] [PDF]

				V. H. Dang, T. H. Nguyen, K.-C. Choi, and E.-B. Jeung A Calcium-Binding Protein, Calbindin-D9k, Is Regulated through an Estrogen-Receptor Mediated Mechanism following Xenoestrogen Exposure in the GH3 Cell Line Toxicol. Sci., August 1, 2007; 98(2): 408 - 415. [Abstract] [Full Text] [PDF]

				V. H. Dang, K.-C. Choi, and E.-B. Jeung Tetrabromodiphenyl Ether (BDE 47) Evokes Estrogenicity and Calbindin-D9k Expression through an Estrogen Receptor-Mediated Pathway in the Uterus of Immature Rats Toxicol. Sci., June 1, 2007; 97(2): 504 - 511. [Abstract] [Full Text] [PDF]

				G.-S. Lee, H.-J. Kim, Y.-W. Jung, K.-C. Choi, and E.-B. Jeung Estrogen Receptor {alpha} Pathway Is Involved in the Regulation of Calbindin-D9k in the Uterus of Immature Rats Toxicol. Sci., April 1, 2005; 84(2): 270 - 277. [Abstract] [Full Text] [PDF]

				Y.-W. Jung, E.-J. Hong, K.-C. Choi, and E.-B. Jeung Novel Progestogenic Activity of Environmental Endocrine Disruptors in the Upregulation of Calbindin-D9k in an Immature Mouse Model Toxicol. Sci., January 1, 2005; 83(1): 78 - 88. [Abstract] [Full Text] [PDF]

				G.-S. Lee, K.-C. Choi, H.-J. Kim, and E.-B. Jeung Effect of Genistein As a Selective Estrogen Receptor Beta Agonist on the Expression of Calbindin-D9k in the Uterus of Immature Rats Toxicol. Sci., December 1, 2004; 82(2): 451 - 457. [Abstract] [Full Text] [PDF]

				K. C Luu, G. Y. Nie, A. Hampton, G.-Q. Fu, Y.-X. Liu, and L. A Salamonsen Endometrial expression of calbindin (CaBP)-d28k but not CaBP-d9k in primates implies evolutionary changes and functional redundancy of calbindins at implantation Reproduction, October 1, 2004; 128(4): 433 - 441. [Abstract] [Full Text] [PDF]

				K. Tatsumi, T. Higuchi, H. Fujiwara, T. Nakayama, K. Itoh, T. Mori, S. Fujii, and J. Fujita Expression of calcium binding protein D-9k messenger RNA in the mouse uterine endometrium during implantation Mol. Hum. Reprod., February 1, 1999; 5(2): 153 - 161. [Abstract] [Full Text] [PDF]

				J. D. Graham and C. L. Clarke Physiological Action of Progesterone in Target Tissues Endocr. Rev., August 1, 1997; 18(4): 502 - 519. [Abstract] [Full Text] [PDF]

				B. Romagnolo, F. Cluzeaud, M. Lambert, S. Colnot, A. Porteu, T. Molina, M. Tomasset, A. Vandewalle, A. Kahn, and C. Perret Tissue-specific and Hormonal Regulation of Calbindin-D9K Fusion Genes in Transgenic Mice J. Biol. Chem., July 12, 1996; 271(28): 16820 - 16826. [Abstract] [Full Text] [PDF]